Viewing Study NCT05775159


Ignite Creation Date: 2025-12-24 @ 2:59 PM
Ignite Modification Date: 2026-01-25 @ 5:03 AM
Study NCT ID: NCT05775159
Status: RECRUITING
Last Update Posted: 2025-11-13
First Post: 2023-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
None Biliary Tract Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatobiliary cancer View
None Hepatocellular carcinoma View
None Biliary tract cancer View
None GEMINI-Hepatobiliary View
None MEDI5752 View
None AZD2936 View
None Bispecific antibody View
None Volrustomig View
None Rilvegostomig View